The T Helper Cell Shift in AIDS: Significance for Pharmacotherapy

Clinical Immunotherapeutics

Volumn 3, Issue 2, 1995, Pages 95-101

  Clerici, Mario ^a   Shearer, Gene M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOTOXIC T LYMPHOCYTE; DRUG THERAPY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNOMODULATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0028878496     PISSN: 11727039     EISSN: 1179190X     Source Type: Journal    
DOI: 10.1007/BF03259271     Document Type: Article

References (66)

1. HIV pathogenesis and long-term survival
2. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1
3. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection
4. Longitudinal study of 94 HIV symptomatic infants with materno-foetal HIV infection: evidence for a bimodal expression of clinical and biological symptoms
5. Incubation period for pediatric AIDS patients
6. Natural history and serologic diagnosis of infants born to human immunodeficiency virus-infected women
7. Trends in survival for children with maternally transmitted acquired immunodeficiency syndrome in New York City, 1982-1989
8. Prognostic factors and survival in children with perinatal HIV-1 infection
9. Basic research comes to the fore as clinical results lag
10. Is HIV associated with a TH1 → TH2 switch?
11. The TH1/TH2 theory of HIV infection: new insights
12. Two types of mouse T helper cell clone: implication for immune regulation
13. TH1 and TH2 cells: different pattern of lymphokine secretion lead to different functional properties
14. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 helper or type 2 helper) profile of cytokine production
15. Human TH1 and TH2 subsets: doubt no more
16. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
17. Cellular immune response to viral peptides in patients exposed to HIV
18. T cell responses to HIV in infected individuals with and without zidovudine therapy and in HIV exposed sexual partners
19. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide
20. T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction
21. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV seropositive individuals
22. HIV-1 exposure indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies
23. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1
24. Cellular immune factors associated with mother-to-infant transmission of HIV
25. HIV-specific T helper activity in HIV seronegative health care workers accidentally exposed to HIV-contaminated blood
26. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
27. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients
28. T-cell proliferation to subinfectious doses of SIV correlates with lack of infection after challenge of macaques
29. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication
30. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus seropositive patients: independence of CD4+ cell numbers and clinical staging
31. The US Air Force HIV study 1985-1990: immunological analyses, seroconversion and the potential utility of a T-helper functional assay to predict change in CD4+ T-cell counts during early stage HIV infection
32. Changes in T helper cell function in human immunodeficiency virus infected children during dideoxyinosine therapy as a measure of antiretroviral activity
33. Changes in interleukin 2 and interleukin 4 production in asymptomatic, HIV-seropositive individuals
34. Role of interleukin-10 (IL-10) in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus (HIV-1)
35. Human B-cell interleukin-10: B-cell lines derived from patients with AIDS and Burkitt lymphoma constitutively secrete large quantities of interleukin-10
36. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients
37. Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection
38. IL-12 deficiency in HIV-infected patients
39. IL-6 in AIDS
40. Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease
41. Serum IgE levels in 622 persons with HIV infection: IgE elevation with marked depletion of CD4+ T-cells
42. Elevation of IgE in HIV-infected subjects: a marker of poor prognosis
43. Antibodies to the CD3/TcR complex induce death by apoptosis in immature T cells in thymic cultures
44. Cell death mechanisms and the immune system
45. Apoptosis and programmed cell death in immunity
46. Mise en evidence d’un processus d’engagement vers la mort cellulaire par apoptose dans les lympocytes de patients infecté par le VIH
47. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis
48. IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes
49. CD3-mediated apoptosis of human medullary thymocytes and activated T cells: respective roles of interleukin-1, interkeukin-2, interferon gamma, and accessory cells
50. Challenges in the therapy of HIV infection
51. Restoration of HIV-specific cell mediated immune responses by interleukin-12 in vitro
52. Jitters jeopardize AIDS vaccine trials
53. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160
54. IL-12: initiation cytokine for cell mediated immunity
55. A strategy for prophylactic vaccination against HIV